skip to Global Navigation Bar skip to main content


homeHome > About Us > Press Release > News

News

News Content
Daewoong Pharmaceuticals expands entry to new markets with license in Mexico and India on Nabota
Date 2016-09-22 Hit 16576
list
News List
Prev Daewoong Pharmaceuticals disseminates the excellence of ‘Nabota’ in IMCAS
Next Daewoong Pharmaceutical’s ‘NABOTA’ becomes the first Korea-made Botulinum Toxin to obtain US FDA approval